BLUECORE COMPANY Co., Ltd. appears in FDA records as the applicant for PicoreMax, cleared as substantially equivalent under K254199 with a decision date of September 24, 2026. The filing lists the device as a powered laser surgical instrument in Class II, regulation 21 CFR 878.4810, product code GEX, reviewed by the General and Plastic Surgery advisory committee. The company's own published page describes the PICOREMAX system and its handpiece tips, while a separate FDA clearance letter from 2024 names Bluecore Company Co., Ltd. as the applicant for Lasya-Trinity. [1][3][5][8]
PicoreMax and its FDA clearance record
The FDA 510(k) database entry for K254199 identifies PicoreMax (PicoreMax) as the trade and device name, with BLUECORE COMPANY Co., Ltd. as applicant and a decision of SESE, described as substantially equivalent. The record shows a Traditional submission, a summary statement, product code GEX, and a decision date of September 24, 2026. The clearance letter addressed to Kwon Bu Gyeong restates the regulation number, regulation name, Class II status and product code, and states that the proposed device has the same intended use and indications, similar technological characteristics and the same principle of operation as the predicate devices. [1][8]
An independent index of the same clearance lists PicoreMax under the General, Plastic Surgery hierarchy at 21 CFR 878.4810 and product code GEX, with the September 24, 2026 decision date and Traditional submission type. The same page reproduces the substantially equivalent conclusion relative to the predicate devices. [7]
Published product description and handpiece technology
The manufacturer’s published PICOREMAX page describes energy output and pulse duration as controlled parameters. It describes a Diffractive Microlens Array (DLA) approach and lists five handpiece tips, including Recurve SS. These are the manufacturer’s own design and component descriptions, rather than FDA findings about clinical performance. [3]
A company announcement states that PICORE MAX is a picosecond laser platform with proprietary DLA technology and that it received FDA 510(k) clearance for specific applications, including tattoo removal and the treatment of certain conditions; the excerpt does not enumerate the remaining conditions. The same announcement links the clearance to the company's global expansion. The FDA record itself documents the clearance and the regulatory classification rather than the marketing framing. [1][4]
Earlier clearance and applicant identity
An FDA clearance letter dated October 10, 2024 addresses Bluecore Company Co., Ltd. regarding K241951 for the trade device Lasya-Trinity, under the same regulation, 21 CFR 878.4810, Class II, product code GEX. The accompanying summary describes a trinity applicator indicated for benign vascular and vascular dependent lesions and an 808 applicator indicated for permanent reduction in hair regrowth. That letter names Sang Mi Oh as official correspondent and lists a Busan address for the applicant. [5]
The K254199 record lists a Yangsan address and Kwon Bu Gyeong as contact, and the manufacturer's published site lists a head office in Yangsan and a Seoul branch. Filing addresses are correspondence details in these records and are not treated here as a verified headquarters designation. No parent company, brand owner or corporate group is confirmed by the available documents. [1][3]
What the collection shows and does not show
As of the snapshot date, the linked collection contains one 510(k) record, K254199, and its decision count is one SESE entry; the smaller record sample likewise contains that single row. These counts describe the linked filings at that moment and are not measures of total company sales, total portfolio or safety performance. No recall records appear in the linked collection. [1]
The documents do not establish clinical outcomes, comparative performance against other lasers, certifications, customer relationships or commercial availability in the United States. The manufacturer's page notes that all Bluecore Company products are medical devices and directs readers to precautions and instructions for use. Details beyond the named clearances and published product descriptions remain unknown. [3][4]

